Neuren Pharmaceuticals Ltd
ASX:NEU

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
ASX:NEU
Watchlist
Price: 21.64 AUD 4.44% Market Closed
Updated: May 31, 2024

Neuren Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neuren Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:
MYX
BOT
PBP
C
CU6
ALA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Neuren Pharmaceuticals Ltd
ASX:NEU
Operating Income
AU$204.9m
CAGR 3-Years
N/A
CAGR 5-Years
102%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Operating Income
-AU$165.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Operating Income
-AU$18.3m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-28%
Probiotec Ltd
ASX:PBP
Operating Income
AU$20m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
30%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Operating Income
-AU$26.4m
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arovella Therapeutics Ltd
ASX:ALA
Operating Income
-AU$9.7m
CAGR 3-Years
-27%
CAGR 5-Years
-31%
CAGR 10-Years
N/A

See Also

What is Neuren Pharmaceuticals Ltd's Operating Income?
Operating Income
204.9m AUD

Based on the financial report for Dec 31, 2023, Neuren Pharmaceuticals Ltd's Operating Income amounts to 204.9m AUD.

What is Neuren Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
102%